The historical rank and industry rank for Agilent Technologies's Gross Margin % or its related term are showing as below:
A'
s Gross Margin % Range Over the Past 10 Years
Min: 50.54 Med: 53.78 Max: 54.54
Current: 54.3
During the past 13 years, the highestGross Margin % of Agilent Technologies was 54.54%. The lowest was 50.54%. And the median was 53.78%.
A's Gross Margin % is ranked better than 56.44% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: 47.865
vs A: 54.30
Agilent Technologies had a gross margin of 53.85% for the quarter that ended in Oct. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Agilent Technologies was -0.40% per year.
Agilent Technologies Gross Margin % Historical Data
The historical data trend for Agilent Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Agilent Technologies's Gross Margin %
For the Diagnostics & Research subindustry, Agilent Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies's Gross Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Agilent Technologies had a gross margin of 53.85% for the quarter that ended in Oct. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Agilent Technologies Gross Margin % Related Terms
Thank you for viewing the detailed overview of Agilent Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
A has been successfully added to your 